SCHEMBL19912495

SCHEMBL19912495

Cc1cc(-c2c(-n3c4ccccc4c4cc(-c5c(C)cc(C)cc5C)ccc43)cc(C#N)cc2-n2c3ccccc3c3cc(-c4c(C)cc(C)cc4C)ccc32)cc(C(F)(F)F)c1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RXRA P19793 1/20 0.33
RXRG P48443 1/20 0.33
MAT2A P31153 1/20 0.33
PTGER4 P35408 1/20 0.32
TACR1 P25103 2/20 0.32
KIF11 P52732 2/20 0.32
PDE9A O76083 1/20 0.31
PDE1C Q14123 1/20 0.31
NR3C1 P04150 1/20 0.31
PGR P06401 1/20 0.31
NR3C2 P08235 1/20 0.31
GABRP O00591 1/20 0.30
GABRD O14764 1/20 0.30
GABRA1 P14867 1/20 0.30
GABRB1 P18505 1/20 0.30
GABRG2 P18507 1/20 0.30
GABRB3 P28472 1/20 0.30
GABRA5 P31644 1/20 0.30
GABRA3 P34903 1/20 0.30
GABRA2 P47869 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19903634 0.97 TACR1 (0.34) RXRARXRGMAT2APTGER4TACR1
SCHEMBL22564381 0.97 RXRA (0.36) RXRARXRGMAT2APTGER4TACR1
SCHEMBL19912500 0.95 KIF11 (0.33) RXRARXRGMAT2ATACR1KIF11
SCHEMBL19912502 0.95 RXRA (0.36) RXRARXRGMAT2AKIF11GABRP
SCHEMBL19912498 0.94 RXRA (0.36) RXRARXRGMAT2APTGER4TACR1
SCHEMBL19912504 0.93 RXRA (0.36) RXRARXRGMAT2APTGER4TACR1
SCHEMBL19912488 0.93 AR (0.36) RXRARXRGMAT2APTGER4TACR1
SCHEMBL19903527 0.92 KIF11 (0.34) RXRARXRGMAT2ATACR1KIF11
SCHEMBL22564368 0.92 RXRA (0.35) RXRARXRGMAT2ATACR1KIF11
SCHEMBL19912476 0.92 RXRA (0.38) RXRARXRGMAT2APTGER4TACR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180062086-A1 ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2018-03-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180062086-A1 ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES OR10J3, ORC3, AOC3 RXRA 3635/4885RXRG 3474/4885MAT2A 2653/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.